Literature DB >> 7152760

HLA antigens in epileptic patients with drug-induced immunodeficiency.

N E Gilhus, J A Aarli, E Thorsby.   

Abstract

Thirty-two patients with epilepsy were typed for 26 HLA-A, -B and -C antigens. Sixteen of the patients were treated with phenytoin. They all had serum IgA concentrations below 0.20 g/l. Another 16 patients received carbamazepine. This group had showed a marked decrease of IgA and IgM serum concentrations during their first month of carbamazepine monotherapy. Among those who showed an IgA deficiency during phenytoin treatment, 14 had the antigen HLA-A2. The frequency of HLA-A2 was similar between controls and patients who had reduced immunoglobulin levels after 1 month of carbamazepine treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7152760     DOI: 10.1016/0192-0561(82)90031-5

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  6 in total

Review 1.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 2.  Immunoglobulins in epilepsy.

Authors:  J A Aarli
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes.

Authors:  F M Schaffer; J Palermos; Z B Zhu; B O Barger; M D Cooper; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  IgG subclasses in epileptic patients treated with phenytoin.

Authors:  N E Gilhus; T Lea
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

5.  Treatment of idiopathic West and Lennox-Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins.

Authors:  K van Rijckevorsel-Harmant; M Delire; M Rucquoy-Ponsar
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

Review 6.  Immunological adverse effects of anticonvulsants. What is their clinical relevance?

Authors:  F De Ponti; S Lecchini; M Cosentino; C M Castelletti; A Malesci; G M Frigo
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.